There’s a moment that keeps returning to me whenever I read medical history: how often the breakthroughs didn’t come from people trying to “change medicine,” but from women trying to fix something that was unbearable.

Not theoretically broken.

Not inefficient on paper.

Unbearable in the body.

And once you start noticing that pattern, you can’t unsee it, because the story stops being about medicine alone.

Take Alice Ball. She is now remembered for developing the first effective treatment for Hansen’s disease (leprosy), but what lingers is not only the chemistry, it is the context in which she worked. At a time when leprosy patients were segregated and largely abandoned by medical institutions, Ball developed a chemically injectable form of chaulmoogra oil that transformed treatment outcomes (Ball, 1915). Her work forced medicine to confront not scientific impossibility, but institutional neglect.

Then the story shifts.

To Florence Nightingale, who is still too often reduced to “the lady with the lamp.” In reality, Nightingale was among the earliest practitioners of applied medical statistics. By collecting and visualizing mortality data during the Crimean War, she demonstrated that unsanitary hospital conditions killed more soldiers than battlefield injuries (Hogben, 1936). Her statistical models reshaped hospital design, sanitation practices, and government health policy, marking a foundational moment in evidence-based medicine (McDonald, 2014).

And from there, the boundary of medicine stretches again.

Marie Curie did not set out to revolutionize healthcare, yet her research on radioactivity fundamentally altered medical diagnostics and cancer treatment. During World War I, Curie organized and deployed mobile X-ray units to battlefield hospitals, enabling surgeons to locate bullets and fractures in real time (National Museum of American History, n.d.). Her work bridged physics and medicine under wartime urgency, long before interdisciplinary science was formally recognized (Quinn, 1995).

The story continues quietly, through objects that look ordinary.

Consider Letitia Mumford Geer, whose one-handed syringe design allowed medical professionals to administer injections without assistance. Patented in 1899, the device increased precision, speed, and independence in clinical settings, particularly for nurses (Geer, 1899). Though modest in appearance, the syringe reshaped everyday medical practice by making care more efficient and scalable (U.S. National Library of Medicine, n.d.).

And while institutional medicine advanced, other women addressed health problems that medicine hesitated to name.

Menstrual health, long treated as a social inconvenience rather than a medical concern, became a site of innovation when women adapted absorbent medical materials into sanitary products during the early twentieth century. These developments were not cosmetic but preventative, reducing infection and improving mobility and school attendance (Freidenfelds, 2009). What emerged was a form of public health intervention, even if it was rarely acknowledged as such (Vostral, 2008).

What connects these women is not a single discipline, but a shared position outside institutional authority.

Many were barred from formal medical training, research posts, or leadership roles. As a result, they approached health problems through chemistry, statistics, engineering, materials science, or fieldwork, solving medical crises from wherever access was possible. Their contributions reveal how medicine itself has been shaped by who was allowed to participate, and who was forced to innovate from the margins.

Seen this way, these are not isolated stories of brilliance. They form a pattern of unrecognized authority, where women repeatedly advanced medical knowledge without being credited as medical pioneers.

What matters to say plainly is that these women represent only a handful among many. For every name that surfaces in the historical record, countless others remain embedded in case notes, lab logs, field reports, and unnamed practices passed from woman to woman. The archive of women’s medical influence is vast, fragmented, and still incomplete, not because the contributions were minor, but because recognition was selective.

Once we tell the story like this, grounded in evidence, yet attentive to lived reality, medicine stops appearing as a neutral march of progress. It becomes a terrain shaped by access, recognition, and power.

And that is precisely the record The She Archive exists to restore.

References

Alice Ball / Leprosy Treatment

Ball, A. A. (1915). The chemical constitution of chaulmoogra oil and its ethyl esters (Master’s thesis). University of Hawaii.

Florence Nightingale / Statistics & Hospital Reform

McDonald, L. (2014). Florence Nightingale at first hand. Wilfrid Laurier University Press.

Marie Curie / Mobile X-Ray Units

Quinn, S. (1995). Marie Curie and the science of radioactivity. Cambridge University Press.

National Museum of American History. (n.d.). Marie Curie and the mobile X-ray units of World War I. Smithsonian Institution.

Letitia Mumford Geer / One-Handed Syringe

Geer, L. M. (1899). Syringe (U.S. Patent No. 625,801). United States Patent Office.

U.S. National Library of Medicine. (n.d.). Medical inventions and innovations by women.

Menstrual Health / Sanitary Products

Freidenfelds, L. (2009). The modern period: Menstruation in twentieth-century America. Johns Hopkins University Press.

Vostral, S. L. (2008). Under wraps: A history of menstrual hygiene technology. Lexington Books.

World Health Organization. (2019). Menstrual health: Global public health perspective.

General (“Handful among many”) framing

Wailoo, K., Livingston, J., & Epstein, S. (2010). Three shots at prevention: The HPV vaccine and the politics of medicine’s future. University of Chicago Press.

Lederer, S. E. (1995). Subjected to science: Human experimentation in America before the Second World War. Johns Hopkins University Press.